Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Retina. 2018 Oct;38(10):1896–1904. doi: 10.1097/IAE.0000000000002302

Figure 2. Cumulative Probability of Diabetic Retinopathy Worsening Among Eyes Treated with Ranibizumab for Diabetic Macular Edema.

Figure 2

Figure 2

Cumulative probability of worsening of diabetic retinopathy by baseline retinopathy subgroup. There was a difference in the rate of worsening between the NPDR and PDR group [P = .01]. There was no difference in the rate of worsening between the 1st, 2nd, 3rd, 4th, and 5th years within each DR group (P > .05). NPDR=non-proliferative diabetic retinopathy, PDR=proliferative diabetic retinopathy.